Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update (2009)
- Autores:
- Autores USP: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1590/s0100-879x2009001100002
- Assuntos: ESQUIZOFRENIA; GLUTAMATOS; CLÍNICAS (EXPERIMENTOS)
- Idioma: Inglês
- Imprenta:
- Local: Ribeirão Preto
- Data de publicação: 2009
- Fonte:
- Título do periódico: Brazilian Journal of Medical and Biological Research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: v. 42, n. 11, p., 2009
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CHAVES, C. et al. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update. Brazilian Journal of Medical and Biological Research, v. 42, n. 11, p. , 2009Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2009001100002. Acesso em: 25 abr. 2024. -
APA
Chaves, C., Marque, C. R. de, Hallak, J. E. C., Sousa, J. P. M. de, Zuardi, A. W., Crippa, J. A. de S., et al. (2009). Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update. Brazilian Journal of Medical and Biological Research, 42( 11), . doi:10.1590/s0100-879x2009001100002 -
NLM
Chaves C, Marque CR de, Hallak JEC, Sousa JPM de, Zuardi AW, Crippa JA de S, Dursun SM, Trzesniak C. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 11): .[citado 2024 abr. 25 ] Available from: https://doi.org/10.1590/s0100-879x2009001100002 -
Vancouver
Chaves C, Marque CR de, Hallak JEC, Sousa JPM de, Zuardi AW, Crippa JA de S, Dursun SM, Trzesniak C. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 11): .[citado 2024 abr. 25 ] Available from: https://doi.org/10.1590/s0100-879x2009001100002 - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol
Informações sobre o DOI: 10.1590/s0100-879x2009001100002 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 001811180.pdf | Direct link |
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
